<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28244">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01683916</url>
  </required_header>
  <id_info>
    <org_study_id>2010-12-198</org_study_id>
    <nct_id>NCT01683916</nct_id>
  </id_info>
  <brief_title>Anesthetic Requirement and Stress Hormone Response During Surgery in Spinal Cord-injured Patients</brief_title>
  <official_title>Chonnam National University Hospital IRB</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonnam National University Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal cord injury (SCI) reduces anesthetic requirements and stress hormonal responses.
      Anesthetic requirements and stress hormone response are compared in SCI patients undergoing
      anesthesia with sevoflurane supplemented with clinically equivalent doses of either N2O or
      remifentanil.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nitrous oxide (N2O) is often used for anesthetic adjuvant, but may be associated with side
      effects and toxicities. Remifentanil shares characteristics with N2O, including
      anesthetic-reducing and antinociceptive effects and a rapid recovery. Anesthetic
      requirements and stress hormone response in SCI patients undergoing anesthesia with
      sevoflurane supplemented with clinically equivalent doses of either N2O or remifentanil.
      Forty-five SCI patients scheduled to undergo pressor sore surgery below the level of the
      injury are randomly allocated to receive either sevoflurane alone (control, n=15), or
      combined with 67% N2O (n=15) or target-controlled infusions of 1.37 ng/mL remifentanil
      (n=15). Sevoflurane concentration is titrated to maintain a Bispectral Index (BIS) value of
      40-50. Measurements include end-tidal sevoflurane concentrations, mean arterial blood
      pressure (MAP), heart rate (HR), and plasma catecholamine and cortisol concentrations.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Complete Spinal Cord Injury</condition>
  <condition>Surgery</condition>
  <eligibility>
    <study_pop>
      <textblock>
        ASA physical status II, with chronic, clinically complete cord injuries scheduled for a
        surgery for pressure sore below the level of the neurologic lesion under general
        anesthesia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status II, with chronic, clinically complete cord injuries scheduled for
             a surgery for pressure sore below the level of the neurologic lesion under general
             anesthesia.

        Exclusion Criteria:

          -  Cardiovascular, pulmonary, or metabolic diseases. Patients who took medications that
             would influence autonomic or cardiovascular responses to the surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine</name>
      <address>
        <city>Gwangju</city>
        <zip>501-757</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young W Won</last_name>
      <phone>82-62-220-6893</phone>
      <phone_ext>6895</phone_ext>
      <email>ywwon@jnu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Kyung Y Yoo, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <lastchanged_date>September 11, 2012</lastchanged_date>
  <firstreceived_date>September 8, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonnam National University Hospital</investigator_affiliation>
    <investigator_full_name>Kyung Yeon Yoo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>spinal cord injury</keyword>
  <keyword>stress hormone</keyword>
  <keyword>surgery</keyword>
  <keyword>bispectral index value</keyword>
  <keyword>volatile anesthetic</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
